Research Article
Clinical and Renal Biopsy Findings Predicting Outcome in Renal Thrombotic Microangiopathy: A Large Cohort Study from a Single Institute in China
Table 2
Treatment of patients with thrombotic microangiopathy.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notes: D + HUS: diarrhea positive hemolytic uremic syndrome; aHUS: atypical hemolytic uremic syndrome; MHT: malignant hypertension; HELLP: hemolysis, elevated live enzymes, low platelet count; HSCT: hematopoietic stem cell transplantation; PI: plasma infusion; PE: plasma exchange; CS: corticosteroid; ACEI: angiotensin-converting enzyme inhibitors; ARB: angiotensin II receptor blockers; CYC: cyclophosphamide; MMF: mycophenolate mofetil; LEF: leflunomide; CsA: cyclosporine A. |